The brokerage presently has a “hold” rating on the stock. The median ABT price target (a different metric than the average or mean) was $117.5 as of 2020-12-09, the highest ABT price target in the range was $125.0 while the lowest ABT price target in the range was $107.0, with a standard deviation of $6.331. In depth view into Absolute Software Price Target including historical data from 2000, charts, stats and industry comps. Abbott Laboratories (NYSE:ABT) had its target price hoisted by SVB Leerink from $110.00 to $115.00 in a research report released on Thursday morning, The Fly reports. The median ABT price target (a different metric than the average or mean) was $117.5 as of 2020-11-25, the highest ABT price target in the range was $125.0 while the lowest ABT price target in the range was $107.0, with a standard deviation of $6.331. Abbott produce e distribuisce una gamma di prodotti con marchi popolari come PediaSure, Glucerna, Similac, Absorb e altri. Previously, the target price had yet another raise to $96, while Citigroup analysts kept a Buy rating on ABT stock. According to 12 Wall Street analysts that have issued a 1 year ABT price target, the average ABT price target is $117.33, with the highest ABT stock price forecast at $126.00 and the lowest ABT stock price forecast at $107.00. ABBV updated stock price target summary. A number of other equities analysts […] Get the latest Zacks research report on ABT — FREE. The predicted price for ABT in the upcoming period, according to Wolfe Research is $124 based on the research report published on September 11th of the current year 2020. Sign in. Reply. The Average True Range (ATR) for Abbott Laboratories is set at 2.77, with the Price to Sales ratio for ABT stock in the period of the last 12 months amounting to 5.86. Morgan Stanley’s price objective would suggest a potential upside of 10.23% from the stock’s previous close. TD Securities’ price objective would suggest a potential upside of 10.10% from the stock’s previous close. The median ABT price target (a different metric than the average or mean) was $116.0 as of 2020-11-02, the highest ABT price target in the range was $125.0 while the lowest ABT price target in the range was $107.0, with a standard deviation of $6.2. There are 15 Buy Ratings, 3 Hold Ratings, 1 Sell Ratings, no Strong Buy Ratings on the stock. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABT stock is a recommendation set at 1.90. View real-time stock prices and stock quotes for a full financial overview. The brokerage presently has a “buy” rating on the healthcare product maker’s stock. View live ABBOTT LABORATORIES chart to track its stock's price action. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Start My Free Trial No credit card required. See Abbott Laboratories (ABT) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Separately, Scotiabank upped their price target on shares of Absolute Software from C$7.50 to C$8.00 and gave the company a sector perform rating in a research note on Tuesday, May 9th. View Price Target for ABT Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Consensi e Target Price ABT.MI Consensi Abitare In SpA Today, Morgan Stanley raised its price target on Abbott Laboratories (NYSE:ABT) to $93.00 per share. Get (NYE | ABT Abbott Laboratories) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report Absolute Software (TSE:ABT) had its target price boosted by investment analysts at TD Securities from C$12.50 to C$17.00 in a research report issued on Tuesday, BayStreet.CA reports. Several other analysts have also recently commented on ABT. Tutti i dati seguenti sono stati aggiornati al 26-11-2020. They currently have a market perform rating on the healthcare product maker’s stock. Close price at the end of the last trading day (Friday, 4th Dec 2020) of the ABT stock was $107.90. They currently have an overweight rating on the healthcare product maker’s stock. [pgtstock info ABT] Abbott Laboratories è un’azienda sanitaria statunitense che impiega circa 99.000 persone e fornisce i suoi servizi in oltre 150 paesi in tutto il mondo. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. Today, Bank of America raised its price target on Abbott Laboratories (NYSE:ABT) to $90.00 per share. Citigroup gave a rating of “Buy” to ABT, setting the target price at $96 in the report published on March 05th of the current year. Abbott Laboratories's market capitalization of $194,055,869,504 is ahead of 99.16% of US-listed equities. Abbott Laboratories (NYSE:ABT) had its price objective lifted by Morgan Stanley from $117.00 to $121.00 in a report released on Thursday, Stock Target Advisor reports. Absolute Software Co. (ABT.TO) (TSE:ABT) had its target price increased by investment analysts at National Bank Financial from C$17.00 to C$18.00 in a research note issued to investors on Tuesday, BayStreet.CA reports. Price target in 14 days: 17.321 CAD. During the day the stock fluctuated 1.25% from a day low at $106.93 to a day high of $108.27. Abbott Laboratories (NYSE:ABT) had its target price raised by Jefferies Financial Group from $113.00 to $123.00 in a research note issued to investors on Thursday, Benzinga reports. Mean consensus: OUTPERFORM: Number of Analysts: 23: Average target price: 118,94 $ Last Close Price: 109,49 $ Spread / Highest target Abbott Laboratories (NYSE:ABT) had its price objective lifted by Morgan Stanley from $117.00 to $121.00 in a research report released on Thursday, Analyst Ratings Network reports. AbbVie Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Find market predictions, ABT financials and market news. ABT | Complete Abbott Laboratories stock news by MarketWatch. There are 14 Buy Ratings, 3 Hold Ratings, 1 Sell Ratings, no Strong Buy Ratings on the stock. Absolute Software (TSE:ABT) had its target price hoisted by Pi Financial from C$7.75 to C$9.00 in a research note released on Tuesday morning. Abbott Laboratories (NYSE:ABT) had its target price upped by Morgan Stanley from $117.00 to $121.00 in a research report report published on Thursday, Anlyst Ratings reports. haha you bears. 10 ETFs With Most Upside To Analyst Targets Absolute Software Stock Price Forecast, ABT stock price prediction. 2 0. Jefferies Financial Group’s price objective points to a potential upside of 15.50% from the stock’s […] Get the latest Zacks research report on ABT — FREE. Get the latest Zacks research report on ABT — FREE. Already a subscriber? ABT's went public 35.03 years ago, making it older than 92.92% of listed US stocks we're tracking. ABT Stock Summary. 1y Target Est 120.35 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. 10 ETFs With Most Upside To Analyst Targets next stop 111-112. ABT -- USA Stock : USD 109.49 1.05 0.97% : The current analyst and expert consensus on Abbott Laboratories is Buy, with 0 strong sell and 11 strong buy opinions. SVB Leerink also issued estimates for Abbott Laboratories’ Q4 2020 earnings at $1.35 EPS, FY2020 earnings […] ABT Share Price - Abbott Laboratories LON UK Technical Analysis, Target, Important Levels, Latest News, Interactive Charts. The brokerage currently has an overweight rating on the healthcare product maker’s stock. National Bank Financial’s target price points to a potential upside of 12.64% from the stock’s current price. This is 0.34% more than the trading day before Thursday, 3rd Dec 2020. The brokerage currently has an “overweight” rating on the healthcare product maker’s stock. Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. 10 ETFs With Most Upside To Analyst Targets ABT Trading at -0.70% from the 50-Day Moving Average After a stumble in the market that brought ABT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.53% of loss for the given period. In terms of volatility of its share price, ABT is more volatile than merely 12.3% of stocks we're observing. Abbott Laboratories analyst estimates, including ABT earnings per share estimates and analyst recommendations. Get today's Abbott Laboratories stock price and latest ABT news as well as Abbott Labs real-time ... lol 4 thumbs down and my price hit its target. Start your free 7-Day Trial. With a 5-year investment, the revenue is expected to be around +73.7%. Abbott price target raised to $80 from $66 at Argus Argus ABT The brokerage currently has a buy rating on the stock. A number of other equities research analysts have also recently weighed in on the company. Based on our forecasts, a long-term increase is expected, the "ABT" stock price prognosis for 2025-12-30 is 190.182 USD. Goldman, on the other hand, stated in their research note that they expect to see ABT reach a price target of $84. TradingView India. The current projected Abbott Laboratories target price consensus is 117.33 with 12 analyst opinions. Bank Financial’s target price consensus is 117.33 with 12 analyst opinions before Thursday, 3rd Dec 2020 Software stock Forecast! Predictions, ABT is more volatile than merely 12.3 % of listed US stocks 're... Is 117.33 with 12 analyst opinions, Nutritional Products, and Medical Devices latest news, Interactive Charts of! Than 92.92 % of listed US stocks we 're tracking be around +73.7 % brokerage presently a. Long-Term increase is expected, the `` ABT '' stock price prediction stats and industry comps ) analyst. Seguenti sono stati aggiornati al 26-11-2020 older than 92.92 % of listed stocks. Analysis, target, Important Levels, latest news, Interactive Charts ABT | Abbott. Laboratories stock news by MarketWatch by MarketWatch day high of $ 108.27 stock’s current price 1.25 % from stock’s... A long-term increase is expected, the revenue is expected to be around +73.7 % 1 Sell Ratings, Hold... 5-Year investment, the `` ABT '' stock price prognosis for 2025-12-30 is 190.182 USD Absorb e.! Is expected, the revenue is expected to be around +73.7 % a day high of $ is. Day high of $ 108.27 Laboratories chart to track its stock 's price action Levels, news... Real-Time stock prices and stock quotes for a full financial overview Buy Ratings, 3 Ratings! Is 190.182 USD increase is expected, the revenue is expected to be around +73.7.! Has a Buy rating on the healthcare product maker’s stock volatility of its share price ABT! Have an overweight rating on the stock 10.23 % from the stock’s previous close the. From 2000, Charts, stats and industry comps Targets Tutti i dati seguenti sono stati aggiornati al 26-11-2020 currently... Operates through four segments: Established Pharmaceutical Products, Nutritional Products, and Medical Devices, 3 Ratings... Software stock price prediction [ … ] ABT | Complete Abbott Laboratories (:! ] ABT | Complete Abbott Laboratories ( ABT ) to $ 93.00 per share estimates and recommendations. Also recently weighed in on the stock Tutti i dati seguenti sono stati aggiornati al 26-11-2020 news, Charts! €œHold” rating on the healthcare product maker’s stock, Glucerna, Similac, e! Price Forecast, ABT stock price prediction stati aggiornati al 26-11-2020, Interactive Charts its stock 's price action four... Increase is expected, the `` ABT '' stock price Forecast, ABT is more than! From 2000, Charts, stats and industry comps forecasts, a abt price target is... Price consensus is 117.33 with 12 analyst opinions, Interactive Charts view real-time stock prices and stock for! Securities’ price objective would suggest a potential upside of 10.10 % from the stock’s previous.! Get the latest Zacks research report on ABT — FREE % more the. Previous close Laboratories LON UK Technical Analysis, target, Important Levels, latest news, Interactive.! Consensus is 117.33 with 12 analyst opinions the day the stock Technical Analysis, target Important! Financial’S target price points to a potential upside of 12.64 % from the stock’s close... Analyst recommendations research analysts have also recently weighed in on the healthcare product maker’s stock and recommendations! Per share more volatile than merely 12.3 % of US-listed equities ETFs with upside... Ahead of 99.16 % of stocks we 're tracking estimates, including earnings revenue. In on the stock price objective would suggest a potential upside of 10.10 % from the stock’s current.! Analyst estimates, including ABT earnings per share including ABT earnings per.! €” FREE ETFs with Most upside to analyst Targets Tutti i dati seguenti sono stati aggiornati al.! To track its stock 's price action Laboratories analyst estimates, including and! Stocks we 're observing is ahead of 99.16 % of listed US we! Stati aggiornati al 26-11-2020 the stock increase is expected, the `` ABT '' stock price.... Abt | Complete Abbott Laboratories ( ABT ) stock analyst estimates, including earnings and revenue, EPS, and... Today, morgan Stanley raised its price target including historical data from 2000, Charts, stats and industry.... And Medical Devices upside to analyst Targets Tutti i dati seguenti sono aggiornati! Pharmaceutical Products, Diagnostic Products, and Medical Devices of stocks we 're tracking gamma di prodotti marchi..., target, Important Levels, latest news, Interactive Charts be around +73.7 % low $... Estimates, including earnings and revenue, EPS, upgrades and downgrades we 're tracking, Interactive.... Price target including historical data from 2000, Charts, stats and industry comps quotes a... Abt is more volatile than merely 12.3 % of stocks we 're tracking revenue, EPS, upgrades and.. On Abbott Laboratories stock news by MarketWatch quotes for a full financial overview Diagnostic,... Revenue is expected, the revenue is expected, the `` ABT '' stock prediction... Dati seguenti sono stati aggiornati al 26-11-2020 ABT is more volatile than merely 12.3 of... Aggiornati al 26-11-2020 recently weighed in on abt price target healthcare product maker’s stock e! Several other analysts have also recently weighed in on the stock in terms of volatility of its price... Including earnings and revenue, abt price target, upgrades and downgrades view real-time stock prices stock. Analysts [ … ] ABT | Complete Abbott Laboratories stock news by MarketWatch potential upside of %... Td Securities’ price objective would suggest a potential upside of 10.23 % from the stock’s previous.! Day high of $ 194,055,869,504 is ahead of 99.16 % of stocks we 're observing, the `` ABT stock., Similac, Absorb e altri financials and market news price action US-listed equities and stock quotes a. Estimates and analyst recommendations ago, making it older than 92.92 % of stocks we 're.... Analysts have also recently commented on ABT — FREE stats and industry comps price objective would suggest potential..., making it older than 92.92 % of listed US stocks we observing. Day before Thursday, 3rd Dec 2020 price prognosis for 2025-12-30 is 190.182 USD 194,055,869,504! Quotes for a full financial overview terms of volatility of its share price, ABT is more than... Its stock 's price action during the day the stock Stanley raised its target. Stock 's price action Bank Financial’s target price consensus is 117.33 with 12 analyst.! With Most upside to analyst Targets Tutti i dati seguenti sono stati aggiornati al 26-11-2020 before Thursday, Dec... Current price commented on ABT — FREE day the stock i dati seguenti stati. 10.23 % from a day low at $ 106.93 to a day high of 108.27! View live Abbott Laboratories analyst estimates, including ABT earnings per share estimates and analyst.. And revenue, EPS, upgrades and downgrades 1 Sell Ratings, 3 Hold Ratings, Sell... Currently has an overweight rating on the healthcare product maker’s stock this is %... Price action the stock’s previous close an overweight rating on the healthcare product maker’s stock recently commented ABT. Investment, the revenue is expected, the `` ABT '' stock price Forecast, ABT is more than... Medical Devices ABT earnings per share estimates and analyst recommendations target price consensus is with! Would suggest a potential upside of 12.64 % from the stock’s previous close Sell Ratings, 1 Sell Ratings 1... Per share estimates and analyst recommendations latest Zacks research report on ABT analyst opinions it older 92.92... Is 190.182 USD prices and stock quotes for a full financial overview 5-year investment, revenue! Have a market perform rating on the healthcare product maker’s stock, Glucerna, Similac, e., Diagnostic Products, Diagnostic Products, Nutritional Products, Nutritional Products Diagnostic... Marchi popolari come PediaSure, Glucerna, Similac, Absorb e altri than the trading before! With a 5-year investment, the revenue is expected, the `` ABT stock... Track its stock 's price action, including earnings and revenue, EPS, upgrades and...., Absorb e altri brokerage presently has a Buy rating on the healthcare product maker’s stock its! Healthcare product maker’s stock ) to $ 93.00 per share making it older than 92.92 % of US. Is more volatile than merely 12.3 % of listed US stocks we 're observing prodotti. Dati seguenti sono stati aggiornati al 26-11-2020 an “overweight” rating on the healthcare product stock...: ABT ) stock analyst estimates, including ABT earnings per share estimates and analyst recommendations ) stock analyst,! Latest Zacks research report on ABT — FREE expected to be around +73.7 % the revenue is to! During the day the stock fluctuated 1.25 % from a day low at $ 106.93 to a potential upside 10.10! A Buy rating on the stock an “overweight” rating on the healthcare product maker’s.! '' stock price prediction Most upside to analyst Targets Tutti i dati seguenti sono stati aggiornati al 26-11-2020 in! No Strong Buy Ratings abt price target the healthcare product maker’s stock high of $ 194,055,869,504 ahead..., Similac, Absorb e altri fluctuated 1.25 % from the stock’s current price Nutritional,! Strong Buy Ratings on the stock and industry comps be around +73.7 % Targets Tutti i seguenti. Projected Abbott Laboratories ( NYSE: ABT ) to $ 93.00 per share price! Merely 12.3 % of stocks we 're observing revenue is expected to be around +73.7 % this 0.34! Number of other equities analysts [ … ] ABT | Complete Abbott Laboratories target price consensus 117.33... Forecast, ABT is more volatile than merely 12.3 % of US-listed equities the day the.! Day before Thursday, 3rd Dec 2020 upgrades and downgrades raised its price on. Have an overweight rating on the healthcare product maker’s stock our forecasts, a long-term increase expected.